Infectious Disease· Topic 7.11 Sexually transmitted diseases and infections of reproductive organs· 7.11.2

Neisseria gonorrhoeae gonococcal infection

Neisseria gonorrhoeae is a gram-negative intracellular diplococcus that infects columnar and transitional epithelium of the cervix, urethra, rectum, pharynx, and conjunctiva, and disseminates hematogenously in 1% to 3% of infections to cause the arthritis-dermatitis syndrome or purulent monoarthritis; treatment is ceftriaxone-based because cephalosporin resistance is emerging and fluoroquinolones are no longer reliable.

15 min read9 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Neisseria gonorrhoeae is a gram-negative intracellular diplococcus that infects columnar and transitional epithelium at nearly any inoculated site: cervix, urethra, rectum, pharynx, and conjunctiva.

  • Epidemiology

    Persons aged 20 to 24 years are at highest risk for N.

  • Risk factors

    Age 20 to 24 years, the single strongest demographic risk factor.

  • Pathophysiology

    N. gonorrhoeae attaches to and invades columnar and transitional epithelium of the endocervix, urethra, rectum, pharynx, and conjunctiva, provoking a neutrophil-rich response that produces purulent discharge.

  • Clinical features

    Urethritis in men: purulent urethral discharge, dysuria, and erythema of the urethral meatus; usually symptomatic, unlike infection in women.

  • Differential diagnosis

    Chlamydia trachomatis infection: indistinguishable urethritis, cervicitis, or proctitis; NAAT shows chlamydia positive and gonorrhea negative.

  • Diagnosis

    Diagnosis is confirmed by nucleic acid amplification testing (NAAT) of the relevant site, the preferred method for genital, rectal, and pharyngeal infection; Gram stain and culture remain the gold…

  • Management

    First, treat uncomplicated cervical, urethral, rectal, or pharyngeal infection with ceftriaxone 500 mg IM single dose (1 g if over 150 kg), preferred since N.

  • Complications

    Disseminated gonococcal infection, in 1% to 3% of untreated infections, as arthritis-dermatitis syndrome or purulent monoarticular arthritis.

  • Prognosis

    Uncomplicated genital, rectal, or pharyngeal gonorrhea resolves reliably with the ceftriaxone regimen, with treatment failure uncommon.

  • Prevention

    Universal ocular prophylaxis at birth: erythromycin 0.5% ophthalmic ointment to both eyes as a single application within 1 hour of birth; do not irrigate away.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.